Pluribus Labs’s McKesson MCK Stock Holding History

Pluribus Labs’s Portfolio MCK Stock Details MCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$492K	Buy	1,509 +678	+82%	+$217K	0.9%	30
2022 Q1	$254K	Buy	831 +1	+0.1%	+$272	1.01%	31
2021 Q4	$206K	Buy	+830	New	+$182K	0.22%	209

Other funds holding MCK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Pluribus Labs's MCK Position: Q2 2022 in Review

Pluribus Labs increased its McKesson (MCK) stake by 82% in Q2 2022, buying an estimated $217K and bringing the position to 1,509 shares worth $492K. The position accounts for 0.9% of the portfolio, ranked #30.

Pluribus Labs first reported a position in MCK in Q4 2021 and has held it in 3 quarters since. 1,167 funds tracked by Wall St. Rank hold MCK as of Q2 2022.

Pluribus Labs held 1,509 shares of McKesson worth $492K as of Q2 2022.
Pluribus Labs bought 678 McKesson shares in Q2 2022, an estimated $217K.
McKesson made up 0.9% of Pluribus Labs's portfolio in Q2 2022, its #30 holding.
Pluribus Labs first reported a position in McKesson in Q4 2021 and has held it in 3 quarters since.
1,167 funds tracked by Wall St. Rank held McKesson as of Q2 2022.

Based on Pluribus Labs's 13F filing for Q2 2022, filed 12 Aug 2022.